Alcohol Use Disorder

FORT LEE, N.J., August 18, 2026 Kedrion Biopharma announced an extension of its U.S. agreement with Grifols to continue...

PALO ALTO, Calif., August 18, 2026 Amygdala Neurosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has...

GAITHERSBURG, Md., Aug. 3, 2026 Altimmune, Inc. has initiated patient enrollment in the global PERFORMA Phase 3 registrational trial...

GAITHERSBURG, Md., July 28, 2026 Altimmune, Inc. announced positive topline results from its Phase 2 RECLAIM clinical trial evaluating...

Vancouver, Canada, July 16, 2026 Clearmind Medicine announced positive ex vivo results demonstrating enhanced nasal retention for its intranasal...

Miami, Florida, USA – April 23, 2026 DemeRx announced that the U.S. Food and Drug Administration (FDA) has accepted...

GLEN ALLEN, Va., April 22, 2026 Adial Pharmaceuticals, Inc. announced the successful completion of demonstration batch production for its...